K Number
K141280
Device Name
ILENS (OCUFILCON D) DAILY SOFT CONTACT LENS
Date Cleared
2014-07-18

(63 days)

Product Code
Regulation Number
886.5925
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The iLens® (ocufileon D) Daily Wear Soft (Hydrophilic) Contact Lens is indicated for daily wear for the correction of refractive ametropia (myopia and hyperopia) in aphakic and/or not-aphakic persons with non-disease eyes in power from -20.00D to +20.00D. The lens may be wom by persons who exhibit refractive astigmatism of 2.0 diopters or less where the astigmatism does not interfere with visual acuity. Eye care prescribe the lens for either single-use disposable wear or for frequent replacement wear. When prescribed for frequent replacement wear, the lens may be disinfected using a chemical or hydrogen peroxide disinfecting system. As prescribed for single use daily dispossble wear, patients are instructed to dispose of the lens at each removal. The iLens® Daily Wear Soft (Hydrophilic) Contact Lenses help protect against transmission of harmful UV radiation to the cornea and into the eye.
Device Description
The iLens® (ocufilcon D) Daily Wear Soft (Hydrophilic) Contact Lens is a . spherical lens with UV blocker. The iLens® (ocufilcon D) Daily Wear Soft (Hydrophilic) Contact Lens is . available in hemispherical shell. The lenses are made of HEMA hydrogel. The composition is 45% ocufilcon D and 55% water by weight when immersed in normal buffered saline solution. The iLens® (ocufilcon D) Daily Wear Soft (Hydrophilic) Contact Lens is light blue tinted with "reactive Blue19" for handling visibility purpose. A benzotriazole UV absorbing monomer is used to block UV radiation. The transmittance characteristics are less than 5% in the UVB range of 280-315nm and less than 50% in the UVA range of 316-380nm. The lens is supplied in a sterile state, packaged in a buffered saline solution.
More Information

No
The 510(k) summary describes a standard soft contact lens made of HEMA hydrogel with a UV blocker. There is no mention of any computational or algorithmic features, let alone AI or ML. The performance studies focus on physiochemical properties and equivalence to predicate devices, not on any data-driven or learning capabilities.

No.
The device is used to correct refractive ametropia (myopia and hyperopia) and protect against UV radiation, not to treat a disease or condition.

No.

The device is a contact lens intended for vision correction (refractive ametropia), not for diagnosing medical conditions.

No

The device description clearly states it is a physical contact lens made of HEMA hydrogel, not software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is for the correction of refractive ametropia (myopia and hyperopia) in the eye. This is a therapeutic and corrective function, not a diagnostic one.
  • Device Description: The description details the physical properties and composition of a contact lens designed to be worn on the eye.
  • Lack of Diagnostic Function: There is no mention of the device being used to analyze samples from the body (like blood, urine, or tissue) or to provide information for the diagnosis of a disease or condition.

IVD devices are used to perform tests on samples taken from the human body to provide information for the diagnosis, monitoring, or treatment of diseases or conditions. This contact lens does not fit that description.

N/A

Intended Use / Indications for Use

The iLens® (ocufilcon D) Daily Wear Soft (Hydrophilic) Contact Lens is indicated for daily wear for the correction of refractive ametropia (myopia and hyperopia) in aphakic and/or not-aphakic persons with non-disease eyes in power from -20.00D to +20.00D. The lens may be worn by persons who exhibit refractive astigmatism of 2.0 diopters or less where the astigmatism does not interfere with visual acuity. The eye care practitioner may prescribe the lens for either single-use disposable wear or for scheduled replacement wear. When prescribed for scheduled replacement, the lens may be disinfected using a chemical (no heat) or hydrogen peroxide disinfecting system. As prescribed for single use daily disposable wear, patients are instructed to dispose of the lens at each removal. The iLens® (ocufilcon D) Daily Wear Soft (Hydrophilic) Contact Lens help protect against transmission of harmful UV radiation to the cornea and into the eye.

Product codes (comma separated list FDA assigned to the subject device)

LPL, MVN

Device Description

  • The iLens® (ocufilcon D) Daily Wear Soft (Hydrophilic) Contact Lens is a . spherical lens with UV blocker.
  • The iLens® (ocufilcon D) Daily Wear Soft (Hydrophilic) Contact Lens is . available in hemispherical shell.
  • The lenses are made of HEMA hydrogel. The composition is 45% ocufilcon D and 55% water by weight when immersed in normal buffered saline solution.
  • The iLens® (ocufilcon D) Daily Wear Soft (Hydrophilic) Contact Lens is light blue tinted with "reactive Blue19" for handling visibility purpose.
  • A benzotriazole UV absorbing monomer is used to block UV radiation. The transmittance characteristics are less than 5% in the UVB range of 280-315nm and less than 50% in the UVA range of 316-380nm.
  • The lens is supplied in a sterile state, packaged in a buffered saline solution.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

eyes / cornea

Indicated Patient Age Range

Not Found

Intended User / Care Setting

eye care practitioner

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Nonclinical Tests Performed

  • 11.1 Physiochemical studies were conducted according to ISO 18369 First edition 2006-08-15, Ophthalmic optics - Contact lenses (Ophthalmic). The physical, optical and chemical properties of the lens are within established specifications for the lenses.
  • 11.2 Toxicology studies report shows that the lenses are non-toxic and biocompatibility result is acceptable in ocular environment.

Clinical Studies
The technical characteristics, formulation, manufacturing, and sterilization processes of the subject device are equivalent to ocufilcon D soft contact lenses currently marketed by CooperVision, therefore no clinical data is required.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K091339

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

K013649, K000384

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 886.5925 Soft (hydrophilic) contact lens.

(a)
Identification. A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.

0

K141280 510(K) SUMMARY

Date of the summary prepared: June 10, 2014

1 Establishment Information:

NameSeinoh Optical Co. Ltd.
Address3F, No. 14, Wucyuan 3rd Rd., Sinjhuang Dist., New
Taipei City 242, Taiwan, R.O.C.
Phone No886-2-2298-8255
Fax No.886-2-2298-8335

2 Owner:

CompanySeinoh Optical Co. Ltd
NameVicent Hu
Address3F, No. 14, Wucyuan 3rd Rd., Sinjhuang Dist.,
New Taipei City 242, Taiwan, R.O.C.
Phone No886-2- 2298-8255 ext: 8858
Fax No. .886-2 —2298-8335

3 US Agent:

CompanyABAND INC.
Address5581 Daniels Street, Unit A, Chino, CA 91710, USA
Phone No(866)-886-8888 (Toll free)
Fax No(909)-627-6207

4 Contact Person:

NameJennifer TING
Phone No886-2-82823192
Fax No886-2-82867686
e-mail:jen.medical@msa.hinet.net

5 Device Identification:

| Proprietary Name | iLens ® (ocufilcon D) Daily Wear Soft (Hydrophilic)
Contact Lens |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Common Name | Soft (hydrophilic) Contact Lenses |
| Classification Name | Lenses, Soft Contact, Daily Wear (21 CFR 886.5925,
Product Code LPL)
Lenses, Soft Contact, Daily Wear (Disposable),
(21 CFR 886.5925, Product Code MVN) |
| Classification | II |

1

6 Legally Marketed Equivalent Device:

Predicate Device NameBiomedics® 55 (ocufilcon D)
ManufacturerCooperVision, Inc.
510(k) NumberK091339
Product CodeLPL, MVN

7 Device Description

  • The iLens® (ocufilcon D) Daily Wear Soft (Hydrophilic) Contact Lens is a . spherical lens with UV blocker.
  • The iLens® (ocufilcon D) Daily Wear Soft (Hydrophilic) Contact Lens is . available in hemispherical shell.
  • The lenses are made of HEMA hydrogel. The composition is 45% ocufilcon D and 55% water by weight when immersed in normal buffered saline solution.
  • The iLens® (ocufilcon D) Daily Wear Soft (Hydrophilic) Contact Lens is light blue tinted with "reactive Blue19" for handling visibility purpose.
  • A benzotriazole UV absorbing monomer is used to block UV radiation. The transmittance characteristics are less than 5% in the UVB range of 280-315nm and less than 50% in the UVA range of 316-380nm.
  • The lens is supplied in a sterile state, packaged in a buffered saline solution. -

8 Indication for Use:

The iLens® (ocufilcon D) Daily Wear Soft (Hydrophilic) Contact Lens is indicated for daily wear for the correction of refractive ametropia (myopia and hyperopia) in aphakic and/or not-aphakic persons with non-disease eyes in power from -20.00D to +20.00D. The lens may be worn by persons who exhibit refractive astigmatism of 2.0 diopters or less where the astigmatism does not interfere with visual acuity. The eye care practitioner may prescribe the lens for either single-use disposable wear or for scheduled replacement wear. When prescribed for scheduled replacement, the lens may be disinfected using a chemical (no heat) or hydrogen peroxide disinfecting system. As prescribed for single use daily disposable wear, patients are instructed to dispose of the lens at each removal. The iLens® (ocufilcon D) Daily Wear Soft (Hydrophilic) Contact Lens help protect against transmission of harmful UV radiation to the cornea and into the eye.

9 Technological characteristics

The spherical lens design specification:

  • · Diameter 13 mm to 15 mm

2

  • Center Thickness 0.08mm @ -3.00D ●
  • (Varies with Power) Base Curve 8.2 mm to 9.2 mm ● . Power -20.00D to +20.00D -6.00D to +6.00D (0.25D increments) +20.00D to +6.50D, -6.50D to -20.00D (0.50D increments)

The physical properties of the lenses are:

  • . Refractive index: 1.405 (hydrated)
  • Light transmittance: > 95%
  • Water content: 55% by weight in normal saline .
  • 20 x 10-11 (Fatt method) Oxygen permeability ●

10 Comparison table:

The characteristic comparison to predicate device is summarized in the following table.

Similarities
ItemDevicePredicate (K091339)
Product NameiLens ® (ocufilcon D) Daily
Wear Soft (Hydrophilic)
Contact LensBIOMEDICS UV SPHERE
Soft Contact Lenses
ManufacturerSeinoh Optical Co. LtdCooperVision, Inc
Intended UseDaily Wear for
Frequent/Planned Replacement
Wear or for Daily disposable
WearDaily Wear for
Frequent/Planned
Replacement Wear or for
Daily disposable Wear
USAN NameOcufilcon DOcufilcon D
MaterialHydrogelThe same
Lens DesignSphericalSpheric, aspheric, toric or
multifocal
ClassificationClass II,The same
TypeGroup IV Ionic High WaterThe same
Water Content55%55 %
Oxygen Permeability
(DK, 35 °C)20
(Fatt method)19.6
(Fatt method)

3

Base Curve Range8.2 mm to 9.2 mm6.50 mm to 10.8 mm
Diameter (mm)13 to 1512.5 ~ 18.0
Center Thickness0.08mm @ -3.00D
(Varies with power)Varies with power (0.025 mm to 0.40 mm)
Powers-20.00D to +20.00D
-6.00D to +6.00D
(0.25D increments)
+20.00D to +6.50D, -6.50D to -20.00D
(0.50D increments)-20.00 D to +20.00 D
Add powers: +0.25 D to +3.00 D
Replacement ScheduleDisposable or Daily wearDisposable or Daily wear
Refractive Index1.4051.41
Light Transmittance>95%>95%
Method of
ManufactureCast-MoldedThe same
Surfactant in the final
Product SalineNoneYes
SterilizationsteamThe same
PackagingBlister packThe same
Blue handling tintYes, reactive Blue19Yes, Entrapment Dye

| Mechanical Strength | Device | Predicate
(K013649) | Predicate
(K000384) |
|-------------------------|-----------|----------------------------------|------------------------|
| Product Name | iLens | Sauflon 55 UV
(methafilcon A) | Frequency 55 |
| Tensile strength (Mpa) | 0.43 | 1.47 | 0.66 |
| Modulus (Mpa) | 0.57 | 0.52 | 0.48 |
| Elongation at break (%) | 55.8 | 280 | 179 |
| toughness (J/m³) | 0.21 | 1.39 | 0.38 |
| Manufacturing method | Cast Mold | Cast Mold | Cast Mold |

4

11 Nonclinical Tests Performed

  • 11.1 Physiochemical studies were conducted according to ISO 18369 First edition 2006-08-15, Ophthalmic optics - Contact lenses (Ophthalmic). The physical, optical and chemical properties of the lens are within established specifications for the lenses.
  • 11.2 Toxicology studies report shows that the lenses are non-toxic and biocompatibility result is acceptable in ocular environment.

12 Clinical Studies

The technical characteristics, formulation, manufacturing, and sterilization processes of the subject device are equivalent to ocufilcon D soft contact lenses currently marketed by CooperVision, therefore no clinical data is required.

13 Conclusion

Comparison to the predicate device for chemical composition, physical and optical properties, it shows that "iLens" (ocufilcon D) Daily Wear Soft (Hydrophilic) Contact Lens" is as safe, as effective and perform as well as the predicate device.

5

Image /page/5/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES (USA)" arranged in a circular pattern around the symbol. The logo is black and white and has a simple, clean design.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

July 18, 2014

Seinoh Optical Co. Ltd. c/o Jennifer Ting Jens Medical Consulting 6F No. 39 Ln. 224. Jixian Road Luzhou Distr. 247. New Taipei City Taiwan ROC

Re: K141280

Trade/Device Name: iLens (ocufileon D) Daily Wear Soft (hydrophilic) Contact Lens Regulation Number: 21 CFR 886.5925 Regulation Name: Soft (hydrophilic) contact lens Regulatory Class: II Product Code: LPL, MVN Dated: May 20, 2014 Received: May 22, 2014

Dear Ms. Ting:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into cither class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

6

Page 2 - Ms. Jennifer Ting

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm 115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Kesia Y. Alexander -S

for Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear. Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

7

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.

510{k) Number (if known) K141280

Device Name

iLens (neufilean D) Daily Wear Soft (Hydrophilic) Contact Lens

Indications for Use (Describe)

The iLens® (ocufileon D) Daily Wear Soft (Hydrophilic) Contact Lens is indicated for daily wear for the correction of refractive ametropia (myopia and hyperopia) in aphakic and/or not-aphakic persons with non-disease eyes in power from -20.00D to +20.00D. The lens may be wom by persons who exhibit refractive astigmatism of 2.0 diopters or less where the astigmatism does not interfere with visual acuity. Eye care prescribe the lens for either single-use disposable wear or for frequent replacement wear. When prescribed for frequent replacement wear, the lens may be disinfected using a chemical or hydrogen peroxide disinfecting system. As prescribed for single use daily dispossble wear, patients are instructed to dispose of the lens at each removal. The iLens® Daily Wear Soft (Hydrophilic) Contact Lenses help protect against transmission of harmful UV radiation to the cornea and into the eye.

Type of Use (Select one or both, as applicable)

2 Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

Joseph C. Hutter -S 2014.07.15 16:00:24 -04'00'

This section applies only to requirements of the Paperwork Reduction Act of 1995.

"DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW."

The burden time for this collection of information is estimated to average 79 hours per response, Including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number.

FORM FDA 3881 (1/14)

PRC Intelleire Seconds (101) 441-67-67-8